http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0795324-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a4a1e9593b4743b897481773bc06c91 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
filingDate | 1997-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2004-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4916924de211b80f295ea2f07777f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6dfed31137f6ad1f991271cec069248 |
publicationDate | 2004-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0795324-B1 |
titleOfInvention | A pharmaceutical tablet characterized by showing a high volume increase when coming into contact with biological fluids |
abstract | A description is given of a pharmaceutical form for oral administration consisting of a two- or three-layers tablet, wherein at least one layer can rapidly swell by contact with biological and/or aqueous fluids, said swelling resulting in a considerable increase in the tablet volume. Said phenomenon determines a prolonged residence of the pharmaceutical form at the gastric level and therefore allows a slow release of the active ingredient from said pharmaceutical form to the stomach and/or the first tract of the intestine. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9622980-B2 |
priorityDate | 1996-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 234.